A randomized phase II trial of sipuleucel-T with concurrent or sequential abiraterone acetate (AA) plus prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC).
暂无分享,去创建一个
C. Redfern | E. Small | N. Dawson | F. Millard | T. Gardner | R. Lance | T. Devries | N. Shore | N. Sheikh | L. Karsh | C. D. Rosa | C. McCoy | A. Stubbs